BKM Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,625
Closed -$599K 165
2024
Q2
$599K Buy
5,625
+328
+6% +$32.9K 0.29% 94
2024
Q1
$512K Buy
5,297
+4,732
+838% +$485K 0.22% 104
2023
Q4
$57K Buy
+565
New +$54.5K 0.02% 246

Other funds holding NVS

BKM Wealth Management's NVS Position: Q3 2024 in Review

BKM Wealth Management sold out of Novartis (NVS) in Q3 2024, closing a stake of 5,625 shares — an estimated $599K sold.

BKM Wealth Management first reported a position in NVS in Q4 2023 and held it in 3 quarters. The position peaked at $599K in Q2 2024. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • BKM Wealth Management reported no remaining Novartis position as of Q3 2024 after selling out during the quarter.
  • BKM Wealth Management sold 5,625 Novartis shares in Q3 2024, an estimated $599K.
  • BKM Wealth Management first reported a position in Novartis in Q4 2023 and held it in 3 quarters.
  • BKM Wealth Management's Novartis position peaked at $599K in Q2 2024.
  • 1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on BKM Wealth Management's 13F filing for Q3 2024, filed 23 Oct 2024.